Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.27
-1.35 (-4.14%)
At close: Aug 28, 2026, 4:00 PM EDT
30.76
-0.51 (-1.63%)
After-hours: Aug 28, 2026, 7:43 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $2.04 billion as of August 28, 2026. Its market cap has increased by 189.64% in one year.
Market Cap
2.04B
Enterprise Value
1.69B
1-Year Change
189.64%
Ranking
Category
Stock Price
$31.27
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $2.04B, an increase of 201.28%. That is a compound annual growth rate of 75.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.04B | 4.57% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 2.13B |
| UroGen Pharma | 2.13B |
| Kailera Therapeutics | 2.10B |
| Vericel | 2.10B |
| Hemab Therapeutics Holdings | 2.09B |
| ADMA Biologics | 2.09B |
| Stoke Therapeutics | 2.04B |
| Zymeworks | 2.01B |